TAXUS VI final 5-year results: A multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions

EuroIntervention

Volumn 4, Issue 5, 2009, Pages 572-577

  Grube, Eberhard ^a   Dawkins, Keith ^b   Guagliumi, Giulio ^c   Banning, Adrian ^d   Zmudka, Krzysztof ^e   Colombo, Antonio ^f   Thuesen, Leif ^g   Hauptman, Karl ^h   Marco, Jean ⁱ   Wijns, William ^j   Joshi, Anita ^b   Mascioli, Stephen ^b  

^a HELIOS Heart Center   (Germany)

^b BOSTON SCIENTIFIC CORPORATION   (United States)

^c OSPEDALI RIUNITI   (Italy)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

^h KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Germany)

ⁱ CLINIQUE PASTEUR   (France)

^j CARDIOVASCULAR CENTER   (Belgium)

more..

Author keywords

Complex lesions; Coronary artery disease; Drug eluting stent; Moderate release; Paclitaxel eluting stent

Indexed keywords

ANTITHROMBOCYTIC AGENT; BIOMATERIAL; CARDIOVASCULAR AGENT; METAL; PACLITAXEL;

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; DRUG ELUTING STENT; EUROPE; HOSPITALIZATION; HUMAN; INSTRUMENTATION; KAPLAN MEIER METHOD; MORTALITY; MULTICENTER STUDY; PROSPECTIVE STUDY; PROSTHESIS; RANDOMIZED CONTROLLED TRIAL; STENT; THROMBOSIS; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ARTERY DISEASE; DOUBLE-BLIND METHOD; DRUG-ELUTING STENTS; EUROPE; HUMANS; KAPLAN-MEIERS ESTIMATE; METALS; PACLITAXEL; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; SEVERITY OF ILLNESS INDEX; STENTS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 65549135156     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV4I5A97     Document Type: Article

References (20)

1. Sousa JE, Costa MA, Abizaid A, Abizaid AS, Feres F, Pinto IM, Seixas AC, Staico R, Mattos LA, Sousa AG, Falotico R, Jaeger J, Popma JJ, serruys PW. Lack of neointimal proliferation after implantation of sirolimuscoated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001; 103: 192-195.
2. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R; RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346: 1773-1780.
3. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE; SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349: 1315-1323.
4. Grube E, Sonado S, Ikeno F, Honda Y, Kar S, Chan C, Gerckens U, Lansky AJ, Fitzgerald PJ. Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer. Circulation 2004;109: 2168-2171.
5. Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, Russell ME. TAXUS I: Six and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 2003;107: 38-42.
6. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, Dudek D, Fort S, Schiele F, Zmudka K, Guagliumi G, Russell ME; TAXUS II Study Group. A randomized study to assess the effectiveness of slow and moderate release polymer-based paclitaxel-eluting stents for coronary lesions. Circulation 2003;108: 788-794.
7. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME; TAXUS-IV Investigators. A polymer-based paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350: 221-231.
8. Meredith IT, Ormiston J, Whitburn R, Kay P, Muller D, Bonan R, Popma JJ, Cutlip DE, Fitzgerald P, Prpic R, Kuntz RE. First-in-man study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I trial. EuroInterv 2005;2: 157-164.
9. Dawkins KD, Grube E, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Popma JJ, Koglin J, Russell ME. Clinical efficacy of polymer based paclitaxel eluting stents in the treatment of complex, long coronary artery lesions from a multi-centre, randomized trial: support for the use of drug eluting stents in contemporary clinical practice. Circulation 2005;112: 3306-3313.
10. Dawkins KD, Grube E, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Popma JJ, Weissman NJ, Koglin J, Russell ME Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents. Eurointerv 2007;3: 213-21.
11. Grube E, Dawkins KD, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Popma JJ, Buellesfeld L, Koglin J, Russell ME. TAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions. Eur Heart J 2007;28: 2578-2582.
12. Eisenberg MJ, Konnyu KJ. Review of randomized clinical trials of drug-eluting stents for the prevention of in-stent restenosis. Am J Cardiol 2006;98: 375-382.
13. Mauri L, Hsieh WH, Massaro JM, Ho KKL, D' Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356: 1020-1029.
14. Moreno R, Fernandez C, Hernandez R, Alfonso F, Angiolillo DJ, Sabate M, Escaned J, Banuelos C, Fernandez-Ortiz A, Macaya C. Drugeluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005;45: 954-959.
15. Ellis SG, Colombo A, Grube E, Friedman M, Baim DS, Stone GW. Long-term safety and clinical efficacy outcomes of the paclitaxel-eluting stent from a patient-level meta-analysis of the TAXUS clinical trials. Paper presented at: Transcatheter Cardiovascular Therapeutics; October 20, 2007; Washington, DC.
16. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O'Shaughnessy CD, DeMaio S, Hall P, Popma JJ, Koglin J, Russell ME; TAXUS V Investigators. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: A randomized controlled trial. JAMA 2005;294: 1215-1223.
17. Park SJ, Shim WH, Ho DS, Raizner AE, Park SW, Hong MK, Lee CW, Choi D, Jang Y, Lam R, Weissman NJ, Mintz GS. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003;348: 1537-1545.
18. Gershlick A, De Scheerder I, Chevalier B, Stephens-Lloyd A, Camenzind E, Vrints C, Reifart N, Missault L, Goy JJ, Binker JA, Raizner AE, Urban P, Heldman AW. Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European Evaluation of Paclitaxel Eluting Stent (ELUTES) trial. Circulation 2004;109: 487-493.
19. Lansky AJ, Costa RA, Mintz GS, Tsuchiya Y, Midei M, Cox DA, O,Shaughnessy C, Applegate RA, Cannon LA, Mooney M, Farah A, Tannenbaum MA, Yakubov S, Kereiakes DJ, Wong SC, Kaplan B, Cristea E, Stone GW, Leon MB, Knopf WD, O'Neill WW; DELIVER Clinical Trial Investigators. Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow- up of the DELIVER clinical trial. Circulation 2004;109: 1948-1954.
20. Serruys PW, Sianos G, Abizaid A, Aoki J, den Heijer P, Bonnier H, Smits P, McClean D, Verheye S, Belardi J, Condado J, Pieper M, Gambone L, Bressers M, Symons J, Sousa E, Litvack F. The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: The PACLITAXEL In-Stent Controlled Elution Study (PISCES). J Am Coll cardiol 2005;46: 253-260.